Did you know?

Oct 10, 2023 · Oct. 9, 2023, 08:25 PM. Truist Financial analyst Joon Lee maintained a Buy rating on Axsome Therapeutics ( AXSM – Research Report) on October 8 and set a price target of $150.00. The company’s ... $AXSM #AxsomeTherapeutics declines in premarket trading. See the latest news. https://marketchameleon.com/Overview/AXSM/Summary/ https://t.co/c4X4KVMGksFeb 17, 2023 · Pre-Earnings Run Up Averaged 3.7% Gains. AXSM is scheduled to report earnings on 27-Feb-2023. The last time Axsome Therapeutics reported earnings on Nov 07, 2022, the stock dropped by -0.5% to close at $56.82. At its current price of $65.98, AXSM post earnings drift is +16.2% . Typically, traders tended to bid up AXSM shares (heading into ... Axsome Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time AXSM stock price.Axsome Therapeutics, Inc. (AXSM) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 70.19 -0.37 (-0.52%) At close: 04:00PM EDT 68.60 -1.59 (-2.27%)Axsome Therapeutics (NASDAQ:AXSM) has risen ~14.5% in the pre-market after the company announced the FDA acceptance of its New Drug Application (“NDA”) for AXS-05 for the treatment of the ...Domino’s Pizza falls after earnings. Shares of Domino’s Pizza fell more than 2% in the premarket after the pizza delivery chain released its third-quarter results. The company earned $4.18 per ...Oct. 9, 2023, 08:25 PM. Truist Financial analyst Joon Lee maintained a Buy rating on Axsome Therapeutics ( AXSM – Research Report) on October 8 and set a price target of $150.00. The company’s ...NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous ...Thinly traded nano cap Axsome Therapeutics (NASDAQ:AXSM) is up 46% premarket on light volume in response to its announcement of positive results from a Phase 2 clinical trial, ASCEND,...Three Motley Fool contributors identified these stocks with huge catalysts on the way: Axsome Therapeutics (AXSM 1.65%), CRISPR Therapeutics (CRSP 0.20%), and Eli Lilly (LLY 3.00%). Here's what ...AXSM stock closed at $56.82 and is up $7.17 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. AXSM has a strong overall score of 83 meaning the stock holds a better value than 83% of stocks at its current price.We would like to show you a description here but the site won’t allow us.Pre-Earnings Run Up Averaged 3.7% Gains. AXSM is scheduled to report earnings on 27-Feb-2023. The last time Axsome Therapeutics reported earnings on Nov 07, 2022, the stock dropped by -0.5% to close at $56.82. At its current price of $65.98, AXSM post earnings drift is +16.2% . Typically, traders tended to bid up AXSM shares (heading into ...

Where the stock market will trade today based on Dow Jones Industrial Average, S&P 500 and Nasdaq-100 futures and implied open premarket values. Commodities, currencies and global indexes also shown.Analysis of Axsome Therapeutics Inc 's fourth quarter 2022 to fourth quarter 2021 Pre-Tax Profit Margin, ranking within Major Pharmaceutical Preparations industry and Healthcare Sector, Pre-Tax Income and Revenue quarterly change - CSIMarketTTOO. T2 Biosystems, Inc. Common Stock. $0.2229 +0.002 +0.91%. Axsome Therapeutics, Inc. Common Stock (AXSM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ...Axsome Therapeutics, Inc. Common Stock (AXSM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

See new Tweets. ConversationThe 12 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 107.26, with a high estimate of 180.00 and a low ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Bonds. This trade is where big investors are . Possible cause: Axsome Therapeutics Inc has gained Wednesday morning, with the stock c.